|
KMID : 0032220190310030335
|
|
Annals of Dermatology
2019 Volume.31 No. 3 p.335 ~ p.338
|
|
|
Omalizumab as a Succesfull Therapy in Normocomplementemic Urticarial Vasculitis: A Series of Four Patients and Review of the Literature
|
|
Degirmentepe Ece Nur
Kiziltac Kubra
Etikan Piril
Singer Ralfi
Memet Bachar
Kocaturk Emek
|
|
|
Abstract
|
|
|
|
Urticarial vasculitis is an eruption characterized by inflamed itchy or painful red papules or plaques that resemble urticaria but last longer than 24 hours and heal with residual pigmentation or purpura. Histopathologically, urticarial vasculitis presents as leukocytoclastic vasculitis with perivascular infiltrate and fibrin deposits. The treatment options are oral antihistamines, oral corticosteroids, dapsone, colchicine and hydroxychloroquine. We report four cases with normocomplementemic urticarial vasculitis who were treated with omalizumab and a brief review of the literature on the use of omalizumab in normocomplementemic urticarial vasculitis.
|
|
|
KEYWORD
|
|
|
Omalizumab, Urticarial vasculitis
|
|
|
FullTexts / Linksout information
|
|
 
|
|
|
Listed journal information
|
|
   
|